Chronic Paroxetine Treatment: Effects on Other Non-Serotonergic Neurotransmitter Systems

E-ISSN： 1996-3181|12|8|1226-1232

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.8, 2013-12, pp. : 1226-1232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel serotonergic and non-serotonergic migraine headache therapies

By Slassi A. Isaac M. Arora J.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 625-649

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine

By Fujishiro J. Imanishi T. Onozawa K. Tsushima M.

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 183-188

Elsevier

Access to resources Recommend Favorite

Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain

By Besson A. Haddjeri N. Blier P. de Montigny C.

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 177-188

Elsevier

Access to resources Recommend Favorite

Effects of the antiparkinsonian drug budipine on central neurotransmitter systems

By Klockgether T. Wullner U. Steinbach J.P. Petersen V. Turski L. Loschmann P.-A.

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 67-73

Elsevier

Access to resources Recommend Favorite

Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus

By Dremencov E. Gur E. Lerer B. Newman M.E.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 729-739

Elsevier

Access to resources Recommend Favorite